How is subcutaneous depot buprenorphine used to treat opioid use disorder in patients with pyloric stenosis?
No direct evidence for the use of subcutaneous depot buprenorphine in patients with pyloric stenosis for opioid use disorder was identified. However, subcutaneous administration may be advantageous by avoiding gastrointestinal complications associated with pyloric stenosis.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-08
- DOI
- https://doi.org/10.5281/zenodo.24056642
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00